HCA Healthcare, Inc. (HCA)
NYSE: HCA · Real-Time Price · USD
362.87
-8.93 (-2.40%)
Jul 16, 2025, 4:00 PM - Market closed
HCA Healthcare Stock Forecast
Stock Price Forecast
The 15 analysts that cover HCA Healthcare stock have a consensus rating of "Buy" and an average price target of $399.31, which forecasts a 10.04% increase in the stock price over the next year. The lowest target is $336 and the highest is $440.
Price Target: $399.31 (+10.04%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for HCA Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 2 |
| Buy | 7 | 7 | 6 | 6 | 6 | 6 |
| Hold | 4 | 4 | 6 | 7 | 6 | 7 |
| Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 17 | 17 | 16 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $390 → $415 | Strong Buy | Maintains | $390 → $415 | +14.37% | Jul 16, 2025 |
| B of A Securities | B of A Securities | Strong Buy → Hold Downgrades $394 → $410 | Strong Buy → Hold | Downgrades | $394 → $410 | +12.99% | Jul 16, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $376 → $404 | Buy | Maintains | $376 → $404 | +11.33% | Jun 23, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $355 → $410 | Hold | Maintains | $355 → $410 | +12.99% | Jun 9, 2025 |
| Barclays | Barclays | Buy Maintains $366 → $416 | Buy | Maintains | $366 → $416 | +14.64% | Jun 2, 2025 |
Financial Forecast
Revenue This Year
75.46B
from 70.60B
Increased by 6.88%
Revenue Next Year
79.28B
from 75.46B
Increased by 5.06%
EPS This Year
25.61
from 22.00
Increased by 16.41%
EPS Next Year
28.43
from 25.61
Increased by 11.00%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 79.6B | 84.9B | 90.4B | ||
| Avg | 75.5B | 79.3B | 83.5B | ||
| Low | 72.2B | 75.7B | 79.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 12.7% | 12.5% | 14.0% | ||
| Avg | 6.9% | 5.1% | 5.3% | ||
| Low | 2.2% | 0.3% | 0.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 27.17 | 31.52 | 35.82 | ||
| Avg | 25.61 | 28.43 | 32.17 | ||
| Low | 24.16 | 26.50 | 30.44 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 23.5% | 23.1% | 26.0% | ||
| Avg | 16.4% | 11.0% | 13.2% | ||
| Low | 9.8% | 3.5% | 7.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.